{"id":4265,"date":"2022-07-19T03:25:51","date_gmt":"2022-07-19T03:25:51","guid":{"rendered":"https:\/\/aceoncology.org\/?p=4265"},"modified":"2022-07-19T03:26:11","modified_gmt":"2022-07-19T03:26:11","slug":"asco-2022-hodgkin-lymphoma-brentuximab-vedotin","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/","title":{"rendered":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624"},"content":{"rendered":"\n<p>\u7ecf\u5178\u578b\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08cHL\uff09\u4e00\u7ebf\u6cbb\u7597\u5177\u6709\u975e\u5e38\u9ad8\u7684\u53ef\u6cbb\u6108\u6027\u3002\u7136\u800c\uff0c\u7ea620%\u7684\u665a\u671fIII\/IV\u671f\u75be\u75c5\u60a3\u8005\u5728\u6807\u51c6\u5316\u7597\u540e\u6709\u590d\u53d1\u7684\u53ef\u80fd\uff0c\u5982\u591a\u67d4\u6bd4\u661f\u3001\u535a\u6765\u9709\u7d20\u3001\u957f\u6625\u82b1\u78b1\u548c\u8fbe\u5361\u5df4\u55ea\uff08ABVD\uff09\u3002\u867d\u7136\u4e2a\u4f53\u5316\u5f3a\u5ea6\u6b63\u7535\u5b50\u53d1\u5c04\u65ad\u5c42\u626b\u63cf\uff08PET\uff09\u5f15\u5bfc\u7684\u6cbb\u7597\u7b56\u7565\u6539\u5584\u4e86\u60a3\u8005\u8010\u53d7\u6027\u548c\u75be\u75c5\u63a7\u5236\uff0c\u4f46\u4e0eABVD\u76f8\u6bd4\uff0c\u8fd9\u4e9b\u65b9\u6cd5\u672a\u663e\u793a\u6709\u610f\u4e49\u7684\u751f\u5b58\u4f18\u52bf\u3002\u57fa\u4e8e\u6539\u5584\u7684\u7ed3\u5c40\u548c\u6709\u5229\u7684\u6bd2\u6027\u7279\u5f81\uff0c\u5305\u62ec\u6297\u4f53\u836f\u7269\u5076\u8054\u7269\u3001\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u548c\u6297PD-1\u514d\u75ab\u6cbb\u7597\uff08\u7eb3\u6b66\u5229\u5c24\u5355\u6297\u3001\u5e15\u535a\u5229\u73e0\u5355\u6297\uff09\u5728\u5185\u7684\u65b0\u7597\u6cd5\u83b7\u6279\u7528\u4e8e\u590d\u53d1\u6027\/\u96be\u6cbb\u6027\u75be\u75c5\uff0c\u76ee\u524d\u5df2\u5728\u65e9\u671f\u6cbb\u7597\u7ebf\u4e2d\u63a2\u7d22\u4e86\u8fd9\u4e9b\u836f\u7269\u4e0e\u5316\u7597\u7684\u8054\u5408\u6cbb\u7597\u3002<br>FDA\u5df2\u6839\u636e\u968f\u673aIII\u671f<a href=\"https:\/\/www.thelancet.com\/journals\/lanhae\/article\/PIIS2352-3026(21)00102-2\/fulltext\">ECHELON-1\u7814\u7a76<\/a>\u7684\u7ed3\u679c\u6279\u51c6\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u4f5c\u4e3a\u65e2\u5f80\u672a\u7ecf\u6cbb\u7597\u7684\u665a\u671fcHL\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\uff0c\u8be5\u7814\u7a76\u663e\u793a\u6539\u826f\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08mPFS\uff09\u663e\u8457\u6539\u5584\u548c\u53ef\u7ba1\u7406\u7684\u5b89\u5168\u6027\u7279\u5f81\u3002\u5728ECHELON-1\u7814\u7a76\u4e2d\uff0c1,334\u4f8b\u65e2\u5f80\u672a\u7ecf\u6cbb\u7597\u7684III\u671f\uff0836%\uff09\u6216IV\u671f\uff0864%\uff09cHL\u60a3\u8005\u63a5\u53d7\u4e866\u4e2a\u5468\u671f\u7684ABVD\u65b9\u6848\u6216\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u52a0\u591a\u67d4\u6bd4\u661f\u3001\u957f\u6625\u82b1\u78b1\u548c\u8fbe\u5361\u5df4\u55ea\uff08A+AVD\uff09\u6cbb\u7597\u3002\u5728ASCO 2022\u5e74\u4f1a\u4e0a\uff0c\u9884\u5148\u89c4\u5b9a\u7684\u4e2d\u4f4d\u968f\u8bbf6\u5e74\u65f6\u603b\u751f\u5b58\u671f\uff08OS\uff09\u5206\u6790\u7684\u6570\u636e\u8fdb\u884c\u4e86\u6c47\u62a5\u3002\u4e0eABVD\u76f8\u6bd4\uff0cA+AVD\u6cbb\u7597\u663e\u8457\u6539\u5584\u4e86OS\uff0c\u6b7b\u4ea1\u98ce\u9669\u964d\u4f4e\u4e8641%\uff08\u98ce\u9669\u6bd4 [HR]\uff0c0.59\uff1bP=0.009\uff09\u3002A+AVD\u7ec4\u4f30\u8ba1\u76846\u5e74OS\u7387\u4e3a93.9%\uff0cABVD\u7ec4\u4e3a89.4%\uff0c\u4e2d\u4f4dOS\u672a\u8fbe\u5230\u3002\u5404\u4e9a\u7ec4\u7684OS\u83b7\u76ca\u57fa\u672c\u4e00\u81f4\uff0c\u5e74\u9f84\u3001\u975e\u767d\u4eba\u3001ECOG\u4f53\u80fd\u72b6\u6001\u548c\u6cbb\u75972\u5468\u671f\u7684PET\u72b6\u6001\u4e0eOS\u7684\u76f8\u5173\u6027\u6700\u5bc6\u5207\u3002\u503c\u5f97\u5173\u6ce8\u7684\u662f\uff0c\u7537\u6027\u60a3\u8005\u6bd4\u5973\u6027\u60a3\u8005\u8868\u73b0\u51fa\u66f4\u597d\u7684\u83b7\u76ca\u3002\u4e0eABVD\u76f8\u6bd4\uff0cA+AVD\u65b9\u6848\u4e5f\u4f7f\u8fdb\u5c55\u6216\u6b7b\u4ea1\u98ce\u9669\u964d\u4f4e\u4e8632%\uff08HR\uff0c0.68\uff1bP = 0.002\uff09\u3002A+AVD\u4e0eABVD\u7684\u4f30\u8ba16\u5e74PFS\u7387\u5206\u522b\u4e3a82.3%\u548c74.5%\u3002\u672a\u62a5\u544a\u65b0\u7684\u5b89\u5168\u6027\u4fe1\u53f7\u3002\u867d\u7136A+AVD\u7ec42\u5e74\u65f6\u6cbb\u7597\u76f8\u5173\u5468\u56f4\u795e\u7ecf\u75c5\u53d8\u7684\u53d1\u751f\u7387\u66f4\u9ad8\uff0867 vs 43%\uff09\uff0c\u4f466\u5e74\u968f\u8bbf\u540e\uff0c\u4e24\u4e2a\u6cbb\u7597\u7ec4\u4e2d\u5927\u591a\u6570\u60a3\u8005\u6d88\u9000\u6216\u6301\u7eed\u6539\u5584\u3002\u91cd\u8981\u7684\u662f\uff0c\u89c2\u5bdf\u5230A+AVD\u7ec4\u7684\u7ee7\u53d1\u6027\u6076\u6027\u80bf\u7624\u8f83\u5c11\uff0823 vs 32\uff09\u3002Stephen Ansell\u535a\u58eb\uff08Mayo\u8bca\u6240\uff0c\u7f8e\u56fd\u7f57\u5951\u65af\u7279\uff09\u63d0\u4f9b\u4e86\u8fd9\u4e9b\u6570\u636e\uff0c\u5e76\u5f97\u51fa\u7ed3\u8bba\uff0c\u6839\u636e\u7ed3\u679c\uff0c\u201c\u5bf9\u4e8e\u65e2\u5f80\u672a\u7ecf\u6cbb\u7597\u7684III\u671f\u6216IV\u671fcHL\u60a3\u8005\uff0c\u5e94\u5c06A+AVD\u89c6\u4e3a\u9996\u9009\u7684\u4e00\u7ebf\u6cbb\u7597\u9009\u62e9\u201d\u3002<\/p>\n\n\n\n<p>\u8ba8\u8bba\u8005Alison J. Moskowitz\u535a\u58eb\uff08\u7eaa\u5ff5\u65af\u9686\u51ef\u7279\u7433\u764c\u75c7\u4e2d\u5fc3MSKCC\uff0c\u7f8e\u56fd\u7ebd\u7ea6\uff09\u6307\u51fa\uff0c\u5f53\u9996\u6b21\u62a5\u544aECHELON-1\u7684<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa1708984\">\u4e3b\u8981\u7814\u7a76\u7ed3\u679c<\/a>\u65f6\uff0c\u4e24\u7ec4\u4e4b\u95f4\u76842\u5e74\u6539\u826fPFS\u4ec5\u663e\u793a\u201c\u9002\u5ea6\u201d\u5dee\u5f02\u3002\u7136\u800c\uff0c\u968f\u7740\u968f\u8bbf\u65f6\u95f4\u7684\u5ef6\u957f\uff0cPFS\u4f18\u52bf\u5f97\u4ee5\u7ef4\u6301\uff0c\u76ee\u524d\u8f6c\u5316\u4e3aOS\u83b7\u76ca\u3002\u6b64\u5916\uff0c\u5979\u5f3a\u8c03\u5728\u4e00\u9879\u65b0\u8bca\u65ad\u4e3a\u9ad8\u5371\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684\u513f\u79d1\u60a3\u8005\uff08\u5e74\u9f84\u8fbe21\u5c81\uff09\u7684III\u671f<a href=\"https:\/\/meetings.asco.org\/abstracts-presentations\/207243\">AHOD1331\u7814\u7a76<\/a>\u4e2d\uff0c\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u6cbb\u7597\u65b9\u6848\u663e\u793a\u4e86\u66f4\u4f18\u7684\u65e0\u4e8b\u4ef6\u751f\u5b58\u671f\uff0c\u98ce\u9669\u964d\u4f4e59%\uff0c\u4e14\u6bd2\u6027\u672a\u589e\u52a0\u3002\u5728\u5979\u7684\u7ed3\u8bba\u4e2d\u63d0\u5230\uff0c\u201c\u6211\u60f3\u8bf4\uff0c\u5728\u8fd9\u4e00\u70b9\u4e0a\uff0c\u5bf9\u4e8e\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff0c\u4ee5\u53ca\u9ad8\u5371\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u513f\u79d1\u60a3\u8005\uff0c\u57fa\u4e8e\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u57fa\u4e0a\u8054\u5408\u5316\u7597\u73b0\u5728\u90fd\u662f\u6807\u51c6\u65b9\u6848\u201d\u3002\u7136\u800c\uff0c\u5979\u6307\u51fa\uff0c\u8fd8\u6709\u8bb8\u591a\u5c1a\u672a\u56de\u7b54\u7684\u95ee\u9898\uff0c\u5305\u62ecPD-1\u6291\u5236\u5242\u662f\u5426\u5e94\u8be5\u7eb3\u5165\u4e00\u7ebf\u6cbb\u7597\u4e2d\u3002\u6b63\u5728\u8fdb\u884c\u7684\u63a2\u7d22\u8be5\u7b56\u7565\u7684\u7814\u7a76\u7ed3\u679c\u503c\u5f97\u671f\u5f85\u3002<\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e\uff1a<\/strong><strong><\/strong><\/p>\n\n\n\n<p>Ansell SM, et al. ASCO 2022: Abstract 7503.<\/p>\n\n\n\n<p>Castellino SM, et al. ASCO 2022: Abstract 7504.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7ecf\u5178\u578b\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08cHL\uff09\u4e00\u7ebf\u6cbb\u7597\u5177\u6709\u975e\u5e38\u9ad8\u7684\u53ef\u6cbb\u6108\u6027\u3002\u7136\u800c\uff0c\u7ea620%\u7684\u665a\u671fIII\/IV\u671f\u75be\u75c5\u60a3\u8005\u5728\u6807\u51c6\u5316\u7597 [&hellip;]<\/p>\n","protected":false},"author":691,"featured_media":4215,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[41],"tags":[],"class_list":["post-4265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-41"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u5728\u665a\u671fIII\/IV\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684OS\u83b7\u76ca\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u5728\u665a\u671fIII\/IV\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684OS\u83b7\u76ca\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-19T03:25:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-19T03:26:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"660\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"j gao\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"j gao\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\"},\"author\":{\"name\":\"j gao\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\"},\"headline\":\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\",\"datePublished\":\"2022-07-19T03:25:51+00:00\",\"dateModified\":\"2022-07-19T03:26:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\"},\"wordCount\":82,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg\",\"articleSection\":[\"\u4f1a\u8bae\u52a8\u6001\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\",\"name\":\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg\",\"datePublished\":\"2022-07-19T03:25:51+00:00\",\"dateModified\":\"2022-07-19T03:26:11+00:00\",\"description\":\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u5728\u665a\u671fIII\/IV\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684OS\u83b7\u76ca\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg\",\"width\":1000,\"height\":660},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\",\"name\":\"j gao\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"caption\":\"j gao\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624 - ACE Oncology","description":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u5728\u665a\u671fIII\/IV\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684OS\u83b7\u76ca","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/","og_locale":"zh_CN","og_type":"article","og_title":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624 - ACE Oncology","og_description":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u5728\u665a\u671fIII\/IV\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684OS\u83b7\u76ca","og_url":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/","og_site_name":"ACE Oncology","article_published_time":"2022-07-19T03:25:51+00:00","article_modified_time":"2022-07-19T03:26:11+00:00","og_image":[{"width":1000,"height":660,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg","type":"image\/jpeg"}],"author":"j gao","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"j gao","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/"},"author":{"name":"j gao","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf"},"headline":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624","datePublished":"2022-07-19T03:25:51+00:00","dateModified":"2022-07-19T03:26:11+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/"},"wordCount":82,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg","articleSection":["\u4f1a\u8bae\u52a8\u6001"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/","url":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/","name":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg","datePublished":"2022-07-19T03:25:51+00:00","dateModified":"2022-07-19T03:26:11+00:00","description":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u5316\u7597\u5728\u665a\u671fIII\/IV\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7684OS\u83b7\u76ca","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-94.jpg","width":1000,"height":660},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/asco-2022-hodgkin-lymphoma-brentuximab-vedotin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u7ef4\u5e03\u59a5\u6614\u5355\u6297\u8054\u5408\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597\u665a\u671f\u970d\u5947\u91d1\u6dcb\u5df4\u7624"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf","name":"j gao","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","caption":"j gao"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/691"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=4265"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4265\/revisions"}],"predecessor-version":[{"id":4266,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4265\/revisions\/4266"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/4215"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=4265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=4265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=4265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}